To test the hypothesis that epidural anesthesia and postoperative epidural analgesia decrease the incidence of death and major complications during and after four types of intraabdominal surgical procedures.
Objective
To test the hypothesis that epidural anesthesia and postoperative epidural analgesia decrease the incidence of death and major complications during and after four types of intraabdominal surgical procedures.
Summary Background Data
Even though many beneficial aspects of epidural anesthesia have been reported, clinical trials of epidural anesthesia for outcome of surgical patients have shown conflicting results.
Methods
The authors studied 1,021 patients who required anesthesia for one of the intraabdominal aortic, gastric, biliary, or colon operations. They were assigned randomly to receive either general anesthesia and postoperative analgesia with parenteral opioids (group 1) or epidural plus light general anesthesia and postoperative epidural morphine (group 2). The patients were monitored for death and major complications during and for 30 days after surgery, as well as for postoperative pain, time of ambulation, and length of hospital stay.
Results
Overall, there was no significant difference in the incidence of death and major complications between the two groups. For abdominal aortic surgical patients, unlike the other three types of surgical patients, the overall incidence of death and major complications was significantly lower in group 2 patients (22%) than in group 1 patients (37%), stemming from differences in the incidence of new myocardial infarction, stroke, and respiratory failure between the two groups. Overall, group 2 patients received significantly less analgesic medication but had better pain relief than group 1 patients. In group 2 aortic patients, endotracheal intubation time was 13 hours shorter and surgical intensive care stay was 3.5 hours shorter.
Conclusions
The effect of anesthetic and postoperative analgesic techniques on perioperative outcome varies with the type of operation performed. Overall, epidural analgesia provides better postoperative pain relief. Epidural anesthesia and epidural analgesia improve the overall outcome and shorten the intubation time and intensive care stay in patients undergoing abdominal aortic operations.
Many beneficial aspects of epidural anesthesia have been reported, including better suppression of surgical stress, positive effect on postoperative nitrogen balance, more stable cardiovascular hemodynamics, reduced blood loss, better peripheral vascular circulation, and better postoperative pain control. [1] [2] [3] [4] [5] [6] [7] The question often asked has been whether these beneficial aspects make a difference in the outcome of surgical patients. Clinical trials for outcome have shown conflicting results, mainly because the number of patients studied was too small, and the factors that influence the outcome (e.g., type of operations, American Society of Anesthesiologists' [ASA] physical status classification, age, gender and, Goldman Risk Index) were not well controlled. 3,8 -12 We present the results of a multiinstitutional clinical trial designed and conducted by the U.S. Department of Veterans Affairs (VA) Cooperative Studies Program with sufficient power to assess the benefits, if any, of epidural plus general anesthesias and postoperative epidural analgesia compared with that of general anesthesia alone and postoperative systemic opioid analgesia in more than 1,000 patients undergoing four types of major intraabdominal operations. We sought to determine whether the use of intraoperative epidural anesthesia and postoperative epidural analgesia affects the rates of perioperative death and major complications, as well as postoperative pain, time of ambulation, and length of hospital stay.
METHODS
The study protocol was approved by the VA Cooperative Studies Program and local institutional review boards in the 15 participating medical centers. Patients gave informed consent before their entry into the study.
Selection and Randomization of Patients
We screened 2,731 patients who were scheduled to undergo any one of the elective surgical procedures in the four intraabdominal surgical groups: aortic (resection of aortic aneurysm, aortic-iliac bypass, aortofemoral bypass); gastric (vagotomy, pyloroplasty, gastroenterostomy, partial/total gastrectomy); biliary (cholecystectomy, cholecystostomy, common bile duct exploration, sphincteroplasty, biliary bypass); and colon (colostomy, colostomy takedown, colectomy, abdominoperineal resection/proctocolectomy) for eligibility for the study. We excluded 1,360 patients from the study who met one or more of the following exclusion criteria: younger than 21 years of age (n ϭ 0); female (n ϭ 21); ASA classification, physical status I, II, V (n ϭ 546); mentally confused (n ϭ 111); scheduled for emergency surgery (cannot be delayed 12 hours) (n ϭ 48); documented myocardial infarction within the past 6 months (n ϭ 18); abdominal procedure within the past 3 months (n ϭ 82); abdominal aortic procedure in the past (n ϭ 30); receiving chemotherapy or immunosuppression therapy (other than steroids alone) (n ϭ 34); tracheostomy or endotracheal intubation (n ϭ 17); hypersensitivity to any study drug (n ϭ 22); contraindications to epidural anesthesia (n ϭ 111); insistence of surgeon or anesthesiologist on using a particular anesthetic (n ϭ 273); and participating in another VA cooperative study (n ϭ 123).
Patients in group 1 (n ϭ 507) would receive general anesthesia plus postoperative analgesia with systemic (intramuscular or intravenous) opioids. Patients in group 2 (n ϭ 514) would receive epidural anesthesia combined with general anesthesia plus postoperative analgesia with epidural morphine.
Assignment
Three hundred fifty otherwise eligible patients declined to participate in the study, leaving 1,021 patients to be randomized. Using an adaptive randomization scheme, 13 within each of the 15 sites, we allocated patients to one of two treatment groups to balance between the groups the following prognostic variables: surgical type (aortic, gastric, biliary, or colon); age (younger than 50 years, 50 -70 years, older than 70 years); and Goldman index 14 (Յ12, 13 and over).
After randomization, surgeons canceled the operations of 26 patients, and 11 patients withdrew from the study. Finally, 495 patients in group 1 and 489 patients in group 2 underwent surgery. We completed 30-day follow-ups for all but 11 study patients.
Preoperative Evaluation
We evaluated all patients by medical history, physical examination, laboratory tests (hematocrit, serum creatinine, serum glutamic-oxaloacetic transaminase [SGOT], blood urea nitrogen, serum electrolytes, total creatine phosphokinase, MB isoenzymes), chest radiography, electrocardiogram, and percutaneous oxygen saturation while breathing room air. All of these tests were performed within 7 days before surgery.
Anesthesia
Premedication consisted of a sedative and/or an opioid administered intramuscularly or orally 1 hour before surgery. An anesthesia resident, a supervised nurse anesthetist, or an attending anesthesiologist administered anesthesia. Minimum monitoring required for the study during surgery included noninvasive blood pressure, heart rate, electrocardiogram, and pulse oximetry. Additional monitoring was used according to the patient's needs.
Patients randomized to group 1 received either sodium thiopental (2-6 mg/kg) or a combination of midazolam (0.02-0.2 mg/kg) and fentanyl (2-20 mcg/kg) for induction of anesthesia. The trachea was intubated with the aid of vecuronium (0.1-0.2 mg/kg). If indicated, endotracheal intubation was accomplished using succinylcholine (1.0 -1.5 mg/kg) or "awake" under topical anesthesia. Anesthesia was then maintained using N 2 O, isoflurane (mean 0.9%), and/or fentanyl (mean 720 mcg). Even though N 2 O and isoflurane were mainly used for maintenance of anesthesia, in some patients who were hemodynamically unstable, anesthesia was maintained using more fentanyl. Vecuronium was administered during surgery as needed for muscle relaxation. At the end of the procedure, vecuronium was reversed by a Vol. 234 • No. 4 Epidural Anesthesia and Analgesia combination of neostigmine (2-4 mg) and atropine (0.8 -1.6 mg). Criteria for extubation included the ability of the patient to generate an inspiratory negative pressure greater than 20 cm H 2 O and a stable cardiopulmonary status.
Patients randomized to group 2 received conventional continuous lumbar or thoracic epidural anesthesia using 0.5% bupivacaine with epinephrine (1:200,000). When a sensory level of T6 or higher was established, the epidural anesthesia was supplemented with general anesthesia using the same anesthetic drugs (e.g., isoflurane [mean 0.5%], fentanyl [mean 360 mcg]) and muscle relaxants used in group 1. To maintain adequate epidural anesthesia during surgery, an additional 5 to 10 mL of the same local anesthetic solution was injected through the epidural catheter every 3 to 5 hours. In this group, surgical anesthesia was provided by epidural anesthesia. The purpose of supplementation with light general anesthesia was to ensure the patient's comfort and to have the patient able to tolerate the endotracheal tube. Extubation criteria, at the end of surgery, were the same as for group 1.
During performance of the epidural block, should a "wet tap" or a "bloody tap" occur, another attempt was made through either a higher or lower intervertebral space. For patients undergoing abdominal aortic surgery, if frank blood was aspirated during the epidural procedure, the procedure was abandoned and rescheduled. During surgery, heparin was administered as needed. After surgery, the epidural catheter was left in place as long as needed for pain management. The catheter was removed only when the prothrombin time and partial thromboplastin time returned to normal.
In both groups of patients, if respiration was inadequate or if the cardiovascular status was unstable at the end of surgery, the endotracheal tube was left in place and the patient's respiration was assisted or controlled with a mechanical respirator after surgery. Every effort was made to extubate the patient as early as possible.
Surgery
All patients received prophylactic antibiotics immediately before surgery and for 24 hours after surgery. All patients undergoing colon procedures had a mechanical bowel preparation with the administration of either oral or intravenous antibiotics perioperatively. All other decisions related to the surgery were left to the discretion of the operating surgeon. The operating surgeon staged the operation by completing one of four staging forms (aortic, gastric, biliary, and colon procedures) adapted from the staging system (and scoring algorithms) developed by the Stanford Center for Health Care Research. 15 Because the staging was done after the procedure, the staging scores were used for a post hoc assessment of balance.
Postoperative Pain Management
For postoperative analgesia, patients in group 1 received morphine or meperidine administered either intramuscularly or intravenously (intermittent or continuous using patientcontrolled analgesia). Patients in group 2 received epidural morphine (0.5 mg/mL, 3-6 mg) immediately before or after surgery. Additional epidural morphine (3-6 mg) was given every 12 to 24 hours, or continuously, for as long as it was needed. In this group of patients, we gave supplemental opioids (morphine or meperidine) intravenously, if necessary. Patients were considered to have had epidural anesthesia if they received any epidural local anesthetics or opioids.
Postoperative Evaluation
All study patients, in addition to the routine postoperative tests, had a 12-lead electrocardiogram taken on the first and third postoperative days. Total creatine phosphokinase and MB isoenzymes were measured every 12 hours for 3 days after surgery.
We recorded the occurrence of any of the predetermined 10 primary or 7 secondary endpoints ( Table 1) during and for 30 days after surgery. Patients were asked to return to the hospital on postoperative day 30 to be examined for the occurrence of primary and secondary endpoints. We evaluated patients who could not return to the hospital by a telephone interview.
We evaluated each patient's postoperative pain and physical performance on postoperative days 1, 3, and 7 or on the day of discharge, if the patient left the hospital before day 7. We assessed postoperative pain at rest using a 0-to-10 visual analogue pain scale (0 ϭ no pain, 5 ϭ moderate pain, and 10 ϭ the most severe pain possible). We assessed physical performance using a seven-level mobilization scale (0 ϭ unable to perform any tasks, 1 ϭ sit up on bedside (feet hanging) with assistance, 2 ϭ sit up on bedside without assistance, 3 ϭ stand with assistance, 4 ϭ stand without assistance, 5 ϭ walk with assistance, and 6 ϭ walk without assistance).
After surgery, we recorded the times patients met predetermined criteria for release from intensive care and discharge from the hospital. Because actual transfers might be influenced by factors other than the patient's health, the times were determined purely by the patient's physical condition rather than the time transfer actually occurred.
Statistical Analyses
Assuming that the proportion of patients in group 1 with major complications would be 15%, the planners of this study thought that if the use of epidural anesthesia and analgesia could halve the major complication rate to 7.5%, this would be a clinically significant result. A sample size of 1,080 patients was selected to detect this difference in proportions at a level of significance of 5% and a power of 90%, allowing for a random 10% loss to follow-up, postrandomization exclusions, or crossovers.
We compared the patients in the two treatment groups to determine whether they were similar with respect to potential confounding variables such as baseline characteristics and surgical staging. Discrete data were compared using a chi-square test; continuous variables were tested using analysis of variance and nonparametric tests (e.g., Wilcoxon rank sum test), as appropriate. To study whether the ran-domization process may have produced treatment groups that are different with respect to important variables, we developed a logistic regression model to predict the likelihood that a patient would be in group 1 or 2 as a function of many independent variables.
We used the contingency table method to test for significant differences in the proportion of patients in the two treatment groups with primary endpoints. We also evaluated whether outcome differences were consistent across the prerandomization stratification variables. The existence of the quantitative and qualitative outcome differences was 
. New myocardial infarction
An increase in the serum concentration of the myocardial-specific isoenzyme fractions of creatine kinase (CK-MB) and lactic dehydrogenase, as evidenced by a ratio of CK-MB/CPK being 5% or more, AND/OR the following EKG changes: A typical new persistent elevation/depression of the ST segment and/or a new Q wave of greater than 0.04 seconds in duration with its depth more than 25% of the amplitude of the succeeding R wave in limb leads, or any new Q wave in V 1 -V 3 . 3. Newly developed or significantly worsened congestive heart failure Dyspnea, basilar rales on lung auscultation and/or an S3 gallop, and confirmation by radiographic changes of pulmonary congestion and/or a pulmonary capillary wedge pressure greater than 20 mm Hg, requiring pharmacologic therapy (digitalis, diuretics, etc.) 4. Persistent ventricular tachyarrhythmia Ventricular tachycardia which lasts longer than 30 seconds and requires pharmacologic therapy.
New complete A-V block
Atrioventricular block which requires placement of a pacemaker.
Severe hypotension (including cardiac arrest)
Mean arterial pressure less than 50 mm Hg, signs of cerebral hypoperfusion or a cardiac index of less than 2.0 liter/minute/m 2 for longer than 10 minutes which required pharmacologic treatment and/or resuscitation.
Pulmonary embolism
An acute onset of dyspnea and tachypnea, hypotension and increased central venous pressure, positive V/Q scan and/or pulmonary angiogram (if performed), requiring medical treatment.
Respiratory failure
The need for intubation and mechanical ventilation for more than 24 hours postoperatively or the need for reintubation and mechanical ventilation after one hour postoperatively.
New cerebral hypoxia/thrombosis/intracranial hemorrhage
The occurrence of new neurologic dysfunction (hemiplegia, hemianesthesia, hemianopia, aphasia, or unconsciousness).
Renal failure
A serum creatinine of greater than 3.0 mg/deciliter and doubling of baseline value, or the need for dialysis.
Secondary endpoint variables 1. Pneumonia
The presence of a new infiltrate on the chest x-ray, plus two of the following three clinical findings (a body temperature higher than 38 degrees Celsius, an abnormal elevation of white blood cell count, a pathogen identified in the sputum by gram stain and culture), requiring intravenous antibiotic treatment.
Sepsis
The presence of a localized infection together with a positive blood culture for the same pathogen plus clinical evidence of bacteremia with chills, rigors, fever, and an elevated white blood cell count, requiring intravenous antibiotic treatment.
Gastrointestinal bleeding
The sudden appearance of frank blood either on nasogastric lavage or per rectum, with a subsequent fall in hemoglobin of 2 grams per deciliter or greater, with no other known or suspected source of ongoing blood loss.
New angina pectoris
A typical chest pain which physicians caring for the patient felt to represent new angina, requiring pharmacologic therapy.
Epidural hematoma
A new occurrence of low back pain, weakness of legs, urinary and/or fecal incontinence, and radiologic signs of spinal cord compression, requiring decompression laminectomy.
Respiratory depression (including arrest)
A new postoperative respiratory depression with a PaCO 2 of greater than 60 mm Hg which physicians caring for the patient felt was associated with an administration of postoperative narcotics, requiring pharmacologic (naloxone) treatment or intubation.
Reoperation for complications
Reoperation (laparotomy or other) for complications related to the primary operation occurring within 24 hours, particularly intra-abdominal infections (abscess or peritonitis), intra-abdominal hemorrhage, and vascular occlusion. Epidural Anesthesia and Analgesia tested by statistical methods developed by Gail and Simon. 16 All variables were tested in univariate fashion to determine which were useful as a prognostic factor of death and major complications. Variables having a P Ͻ .10 were considered potentially predictive. All such predictive variables were entered as independent variables into a multivariate logistic regression model where the probability of dying or experiencing one of the major complications was the dependent variable. Both forward and backward stepwise procedures were used. These analyses were designed to reveal which variable or variables, in the presence of the other variables, remained a potent predictor.
To adjust for the possibility that differences in preoperative risk factors may be responsible for the results, we compared the results of two logistic regression models: one logistic model involving treatment alone, with another model including treatment and all the significant predictors. This was performed for all the patients who had surgery as well as for patients with each surgery type. For all analyses, the intent-to-treat analysis is presented, and a difference is designated as statistically significant at P Ͻ .05, two-tailed.
RESULTS

Baseline Characteristics
Overall, our stratified randomization succeeded in balancing important confounding variables that might influence outcome between the two groups-in other words, the patient's preoperative baseline characteristics (Table 2 ) and the staging scores for severity of surgical disease and complexity of operation for each surgery type (Table 3 ). To study the success of the randomization process in a multivariate way, we developed a logistic regression model to predict the likelihood that a patient would be in group 1 or 2 as a function of many independent variables; none of the variables was a significant predictor, confirming the univariate analysis result that the two treatment groups were similar at the time of treatment assignment.
Intraoperative Monitoring
In addition to the minimum monitoring required for the study, end-tidal C0 2 was monitored in 980 (96%) patients, direct arterial pressure (A-line) in 776 (76%), central venous pressure in 572 (56%), and other hemodynamics using a Swan-Ganz catheter in 419 (41%). In aortic surgery patients, A-line was used in 371 (99%) of the patients and a Swan-Ganz catheter in 329 (88%). There was no significant difference in monitoring between the two groups.
Primary and Secondary Endpoints
Overall, the 30-day follow-up data showed no significant differences in occurrence rates of primary and secondary endpoints between the two treatment groups. A comparison of the 10 individual primary endpoints and the 7 individual secondary endpoints also showed no significant differences between the two groups, although the incidence of respiratory failure (P ϭ .06) and angina pectoris (P ϭ .07) approached statistical significance (Table 4) ; however, the number of patients with angina pectoris was small.
A logistic regression analysis identified six variables (age, ASA status, congestive heart failure, chronic obstructive pulmonary disease [COPD], renal failure, and duration of surgery) as significant predictors of primary outcome (P Ͻ .01). Although renal failure was a significant predictor, the number of patients in our study was small. To examine the possibility that differences in preoperative risk factors may have altered these results among patients undergoing the four types of surgery and receiving different treatment, we compared the logistic model involving treatment alone with the model with treatment and the significant predictors. Adjusting for the presence of the covariates did not alter the relationship between primary outcome and treatment.
Analysis by Important Prognostic Variables
We found significant outcome differences across surgery types but not across age groups, Goldman indices, and hospitals. These subgroups were identified at the beginning of the study. An analysis by type of operation showed that for abdominal aortic surgery patients, the 30-day postoper- ative overall occurrence rate of primary endpoints was significantly lower (P Ͻ .01) in group 2 patients (40/184, 22%) than in group 1 patients (70/190, 37%). This difference stemmed from the increased incidence in group 1 patients of new myocardial infarction, respiratory failure, and stroke (Table 5 ). For the aortic surgery patients (n ϭ 374), there were four significant predictors of primary outcome: age, congestive heart failure, COPD, and duration of surgery. Even after adjusting for the impact of these predictors by comparing logistic regression models, the group 2 patients still had a significantly lower occurrence rate of primary endpoints. In aortic surgery patients, there were more smokers (P ϭ .03) in group 2 than in group 1. Otherwise, our stratified randomization gave good balance among important potential confounding factors that might influence outcome from operation ( Table 6 ). This finding was confirmed by a multivariate logistic regression analysis. Table 6 shows that aortic surgery patients had a lower Goldman cardiac risk index but were more likely to be hypertensive, have COPD, and have a history of alcoholism and smoking than nonaortic surgery patients.
Further analysis by type of operation revealed that for each of the other types, biliary (n ϭ 98), gastric (n ϭ 77), and colon (n ϭ 397) operations, important prognostic fac-tors were well balanced between the two groups, and there were no significant differences in the overall as well as individual occurrence rates of either primary or secondary endpoints between the two treatment groups.
Postoperative Pain Control, Ambulation, and Hospital Stay
Overall, of the 507 group 1 patients, 35 received postoperative opioids intramuscularly (7%) and the others received opioids intravenously, with 123 (26%) of them using patient-controlled analgesia. Of the 514 patients in group 2, 293 received epidural morphine intermittently (57%), and the others received morphine intermittently, continuously, or both. There was no significant difference in the route of opioid administration among the four surgical types.
Group 2 patients reported significantly better postoperative pain control (P Ͻ .01) than did group 1 patients( Table  7 ). The total amount of opioid administered after surgery was significantly less (P Ͻ .01) in group 2 patients. In Group 2 patients, epidural catheters were used for a mean of 55.2 hours after surgery.
Patients in both groups had similar overall postoperative Epidural Anesthesia and Analgesia physical performance on postoperative days 1, 3, and 7. Patients in group 2 were extubated about a half-hour earlier than those in group 1 (P ϭ .02). There were no significant differences in length of intensive care unit stay or hospital stay between the two groups (see Table 7 ). Aortic surgery patients in group 2 had better pain control (P Ͻ .01) than group 1 patients on postoperative day 1. However, pain control on postoperative days 3 and 7 was similar for the two groups. Group 2 patients received less analgesic medication (P Ͻ .01) than group 1 patients. On postoperative day 3, group 2 patients had better physical performance (P ϭ .05) than group 1 patients. Group 2 patients were extubated 13 hours earlier (P ϭ .01) and had a shorter intensive care stay by about 3.5 hours (P ϭ .02). However, the duration of hospital stay was not statistically different between the two groups (see Table 7 ). The above results stem from an "intent-to-treat" analysis, and the results of the "actual treatment" analysis agreed entirely.
We had 48 patients cross over from group 1 to group 2; 37 of these patients had both epidural anesthesia and epidural analgesia, and the remaining 11 patients had general anesthesia and epidural analgesia. We had 32 patients cross over from group 2 to group 1; all of these patients had general anesthesia and systemic (intramuscular or intravenous) analgesia. In group 2, 427 (83%) patients had an epidural anesthesia level higher than T6 before induction of general anesthesia.
DISCUSSION
Our findings suggest that the effect of anesthetic and postoperative techniques on perioperative outcome varies with the type of operation performed. Overall, the two anesthesia techniques compared in the study made no difference in the overall rates of death and major complications in patients undergoing four types of intraabdominal operations. However, we did find a decreased incidence of myocardial infarction, respiratory failure, and stroke in patients who received epidural anesthesia combined with general anesthesia and epidural analgesia in aortic surgery patients but not in biliary, gastric, and colon surgery patients. Two previous studies, one with diverse surgical patients 3 and one with patients undergoing aortic or lower extremity vascular procedures, 12 reported reduced rates of death and major complications in patients who received epidural anesthesia plus general anesthesia and postoperative epidural analge- sia. Five other studies of patients undergoing aortic procedures, abdominal procedures, and lower extremity vascular procedures found no difference in the rates of death and major complications between the two types of anesthesia. 8 -11,17 These conflicting results could have been attributed to the fact that they studied a small number of patients and different types of operations, using different methods for postoperative pain control. A recent overview found that performing procedures with some type of neuraxial blockade reduces the death rate by one third and reduces the odds of deep vein thrombosis, pulmonary embolism, pneumonia, and respiratory depression. 18 There have been reports of beneficial effects of epidural anesthesia and postoperative epidural analgesia on the perioperative outcome in high-risk patients on the basis of their medical condition and major surgical procedures. 3, 19 We observed significant differences in baseline characteristics of patients undergoing aortic versus nonaortic procedures. Patients undergoing aortic procedures had more hypertension, COPD, a history of current smoking, and alcoholic liver disease, even though their Goldman index scores were lower. Also, in general, aortic procedures are considered to be more major surgical procedures than the other nonaortic procedures studied. Mean operative time was greater in the aortic group. Thus, overall, aortic patients in this study were higher-risk patients. Our findings in aortic patients, and those of other investigators mentioned above, suggest that epidural anesthesia with postoperative epidural analgesia reduces the incidence of perioperative death and major complications only in high-risk surgical patients.
We designed this clinical trial to compare the incidence of death and major complications between the two treatment groups, not to determine the pathophysiologic mechanisms of any differences. We can only speculate about the mechanisms involved in the better outcome with epidural anesthesia and analgesia in abdominal aortic surgery patients. Some mechanisms previously suggested for better outcomes with epidural anesthesia and analgesia include possible systemic and coronary vasodilatation with reduction in cardiac preload and afterload, resulting in more stable hemodynamics with fewer episodes of myocardial ischemia during critical times of aortic clamping and unclamping, improved postoperative pain control, and possibly other factors yet to be determined. 3, 20 We need further studies to determine the mechanisms involved in the better outcome we have documented with epidural anesthesia and analgesia in abdominal aortic patients.
In this study, patients who received epidural anesthesia combined with general anesthesia and postoperative epidural analgesia had better pain control than those who received general anesthesia and postoperative systemic opioids. Other investigators also reported that epidural opioid analgesia was superior to traditional systemic or even intravenous patient-controlled opioid analgesia in reducing postoperative pain, especially with thoracic and upper abdominal surgery. 19 -21 Even though there were no differences in outcome between the two groups in the nonaortic abdominal surgical patients, the better pain relief provided by epidural analgesia alone may justify the use of epidural analgesia for these patients who are expected to have severe postoperative pain. The strengths of this large, multiinstitutional randomized clinical trial lie in its size and generalizability. This was a large study: the sample sizes for the overall study were 507 and 514 patients, and those for abdominal aortic surgery were 190 and 184 patients in each of the two treatment groups, respectively. However, despite this, the actual power for distinguishing treatment differences in the overall study remained low because the observed complication rates differed from the anticipated projected rates. Although the planning committee originally thought that the major complication rate in patients given general anesthesia plus systemic opioid analgesia would be 15%, the observed rate was 22%. If we had started with the intention of trying to detect a moderate effect size (e.g., a 30% reduction), then 510 patients in each group would have provided a power of 77% to detect this difference.
The other strong feature of this study lies in the generalizability of our findings to widespread clinical practice. Our design, with its broad inclusion of a variety of common intraabdominal procedures, use of anesthetic techniques and agents familiar to most anesthesiologists, and the participa-tion of numerous anesthesiologists and surgeons from 15 Veterans Affairs Medical Centers across the United States, leans sharply toward ease of generalizability. The differences we report between the two treatment arms in this trial are therefore likely to be similar to those achieved by anesthesiologists and surgeons in widespread U.S. clinical practice. However, this generalizability is at the expense of potential pitfalls in interpretation because of different drug doses and different routes of administration of pain medication, variables for which the planners of the study considered but ultimately rejected standardizations across sites because of anticipated low acceptability and feasibility. The Goldman index did not lead to useful stratification, and a more sophisticated assessment of cardiac status may be needed in future studies.
In conclusion, our study shows that the effect of anesthetic and postoperative analgesic techniques on perioperative outcome varies with the type of operation performed. Epidural anesthesia plus epidural analgesia improve the overall outcome, provide better pain control, and shorten intubation time and intensive care stay in patients undergoing abdominal aortic operations. Further studies are needed not only to distinguish the impact of intraoperative epidural anesthesia from that of postoperative analgesia but also to establish the impact of specific agents and modes of opioid analgesia within the systemic or epidural groups on outcome.
Discussion
DR. WILLIAM H. PEARCE (Chicago, Illinois): This issue of epidural versus general anesthesia has been debated for the past 20 years. As you review the literature, you find that it is filled with variability in surgical technique as well as anesthetic technique. In addition, the literature poorly categorizes patients according to co-morbidities. This study has done an outstanding job in randomizing the two groups. I have four questions for you.
The first is that you demonstrated differences in cardiopulmonary comorbidities between the two groups. During aortic surgery hemodynamic instability can occur with aortic cross-clamping and velase. I wonder if you saw a difference or had that level of detail to see the hemodynamic instability during that period of time. At our own institution where we do these procedures with general anesthesia, we have close communication with our anesthesiologists and therefore minimize this period of hemodynamic instability.
The second question is, when you divided the groups into aortic versus non-aortic did you did you cut the power of your study by reducing your N? 
Epidural Anesthesia and Analgesia
The third question is, beta blockers appear to play an important role in the perioperative cardiovascular morbidities. Did you control for beta blockers and their use during the study.
Finally, it may be difficult to generalize the study. Fifteen different centers participated in this study. What was the distribution of cases contributed by each center. This was done over, I believe, four years, and therefore the individual contribution may be ten cases or less.
PRESENTER DR. JON S. THOMPSON (Omaha, Nebraska): Thank you, Dr. Pearce. I didn't have time to show all the detail here.
Your first question was about some of the technical details -e.g. cross-clamping and intraoperative hypotension. The staging scores actually include items such as that. Where you cross-clamp, for example, and the duration of intraoperative hypotension are the types of things that get scored in the staging system, and particular weight being given to each one. Thus, this would have been controlled by the surgical staging system between the groups.
You are right, the study was designed and powered overall based on the overall outcome of the study. For the aortic and the colonic groups, where there were approximately 200 patients in each arm, the power is still probably adequate to make these conclusions. In the gastric and biliary groups this probably is not true and we can't make some strong conclusion based on those two groups of patients.
This study was designed several years ago, and at that time beta blockers and their effects were probably not as widely appreciated. So unfortunately, this was neither specified, excluded, or sought for. That certainly could be a confounding factor which was not anticipated at the beginning. Hopefully it would have been controlled just as part of the general randomization process.
There were 15 hospitals in the study, and there were volume differences. While we have not totally analyzed for outcome differences, we did not see a significant difference among the institutions despite the difference in volume that occurred.
DR. DOUGLAS W. WILMORE (Boston, Massachusetts): This last December, the British Medical Journal published an exceedingly comprehensive evaluation of the effects of epidural and spinal anesthesia versus general anesthesia on outcome in surgical patients.
Epidural anesthesia was associated with a 30% reduction in mortalitylet me repeat that, a 30% reduction in mortality -which is a tremendous effect on survival. Remember that most of the block-buster drugs that are now sold at best reduce mortality only 6 or 7%. This tremendous effect on mortality had other benefits such as a marked reduction in thromboembolic disease, pneumonia, and death from sepsis.
Many of the patients in this particular study came from groups primarily undergoing orthopedic procedures or those undergoing GYN procedures in the lower abdomen, and the real importance of this perspective randomized multi-center trial that Dr. Thompson and his associates bring to us is that it is one of the first large groups of general surgical patients receiving epidural anesthesia. Dr. Thompson, we are indebted to you and your collaborators for bringing this information to us. I offer several questions for clarification.
What was the target level of the epidural that your anesthesiologists sought to achieve? Were you up to T-4, T-6 or T-8?
How long was the epidural kept in place? There is good evidence that you need 36 to 48 hours of epidural anesthesia in the postoperative period to really maximize the effects of this approach. Could you tell us about how long the epidurals were in place?
One of the concerns about epidurals is the relationship between anticoagulation and epidural or spinal anesthesia with a catheter in place. What did you use for prophylaxis for thromboembolic disease? And was bleeding in the epidural space a problem?
Finally, did you have specific protocols for care of the epidural patients? If you used specific protocols, as others have reported, you can initiate oral feedings soon after the operation because of the decreased illius, and many physicians using epidural techniques will ambulate patients within 18 hours of operation. But you need specific nursing care protocols to accomplish these functions. If these protocols are in place, others have reported reduced length of stay. It would be important to know if those types of protocols were followed.
In patients who can't get an epidural or epidural is contraindicated, is beta blockade using systemic blockers an alternate approach?
Finally, we should thank your group for bringing this approach to our attention. As we move into the future with our anesthesiology colleagues, the data really says that we have to move away from general anesthesia with the administration of three drugs and an endotracheal tube to therapies which are modifying the sympathetic nervous system. That can be epidural anesthesia, that can be beta blockade, and there may be other techniques yet forthcoming. It appears that if we do modify the stress response to operation, we can really improve outcome for our patients.
DR. JON S. THOMPSON: Thank you, Dr. Wilmore, for your questions. As I mentioned, the level sought was T-6. This was achieved in about 85% of the patients with a block. The median duration of epidural use was 55 hours. And there obviously was some range there. But I think particularly with terminal injections that we really mirrored the general use of with this technique at the present time.
At the time we developed the study, there was concern about the use of anti-coagulation and placement of the catheters. Obviously the large group of patients undergoing aortic procedures were going to be systemically anti-coagulated during the procedure, so there was a protocol for what to do if you received a wet tap and sometimes even the operations needed to be delayed in that group.
Otherwise, there really was no specific protocol that was maintained to prevent venous thrombosis and pulmonary embolus. I believe overall, based on the discussion during the design phase, that there was a fairly low use of low-dose heparin in the management of these patients during the initial period. Intermittent compression stockings were employed. This is not something that was mandated across the study centers. There was a remarkably low incidence of complications related to the epidural. There were no hematomas.
As you can imagine, in the VA system with 15 centers, generalizability became an issue. We wanted to manage the two groups of patients similarly. This was not a blinded study. The intent was that whether they are in the general or epidural group they were managed the same in terms of physical performance and other parameters.
We did not specifically look at the issue of ileus. Both myself and others have studied this in small uncontrolled trials to see what the benefits might be. We in this study tried to focus on the major end-points, but this certainly is another advantage that needs to be explored.
As I mentioned before, I think because of the limitations in the design from the standpoint of the new information, such as the beta blockers, certainly the magnitude of the changes that we observed here would be modified by specific changes in the protocol or other agents.
DR. G. MELVILLE WILLIAMS (Baltimore, Maryland): We have done two studies at John Hopkins and felt that in both studies it was important to place epidural catheters in all patients. So some received drugs, some did not. This was a completely blinded study in both cases.
In the first study, we terminated the study because we found with peripheral vascular procedures that we had more acute occlusions of our saphenous vein bypasses in the groups that did not receive the epidural drug. So there was a salutary benefit to receiving epidural anesthesia.
However, when it came to the aortic procedures, this completely blinded study ended up with basically no difference in any of the important variables, with the possible exception that pulmonary complications. There was a trend toward improvement in patients with pre-existing pulmonary disease who had epidural drugs.
The question that I raise is the bias, which happens when you are not blinded. The temptation would be, 'Well, this patient has epidural, let's go ahead and feed him, this patient is epidural, let's extubate him,' and so forth. So unless you do a blinded study, I raise the question of what the import would be. Despite your care in trying to control for variables, might there be some prejudice with regard to certain of these variables?
DR. JON S. THOMPSON: Thank you, Dr. Williams. We are aware of your work. As I mentioned earlier, unfortunately at the time the study was designed the regulatory groups thought it would be inappropriate for to us blind the study. I think that stands as a potential deficiency that would need to be addressed.
DR. ROBERT H. BOWER (Cincinnati, Ohio): This study was performed in VA medical centers with varying anesthesia personnel resources. Can you comment on the cost or utilization of resources required for preoperative placement of epidural catheters and the increased requirements of personnel to monitor and adjust the postop analgesia?
DR. JON S. THOMPSON: This study was not designed to look at cost utilization per se. Those of us who use this modality are aware that unless the anesthesia team is organized to do this, there can be a significant delay in the start of cases. This was not specifically looked at. I believe we do have data about how long it took to place them and so forth, and it was in the half hour range.
During the development of this study epidural and parenteral analgesia could not be routinely carried out by patient control techniques because of resource issues. Obviously the catheters also require additional attention from anesthesia personnel after hours to carry out these techniques. I think that is another question that needs to be investigated. In the current environment actually we are able to carry this out quite well. Vol. 234 • No. 4 Epidural Anesthesia and Analgesia
